TSE:5621 stock news
This page provides real-time market news, earnings updates, and company announcements related to Human Technologies,Inc. (TSE:5621).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-19 07:33 JST
“AI Can’t Touch Cash”: BitGo CEO Sees Crypto as AI’s Native Currency
CoinEdition2026-02-18 05:12:18
Black Swan Fund founder warns that the S&P 500 may surge to 8,000 points before a sharp reversal
AIcoin2026-02-18 06:33:07
CervoMed's neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
Finviz2026-02-18 11:03:09
Fiverr Stock Hits 52-Week Low - Here's Why
Finviz2026-02-18 11:36:44
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Finviz2026-02-18 12:03:22
Upwork Announces $300 Million Share Repurchase Program
Finviz2026-02-18 12:03:22
Amazon Abandons Blue Jay Warehouse Robot In Less Than Six Months, Pivots To New Technologies: Report
Finviz2026-02-18 12:21:40
SailPoint Announces Date of Fiscal Fourth Quarter and Full Year 2026 Earnings Conference Call
Finviz2026-02-18 13:03:47
Aprea Therapeutics Announces Additional Positive Clinical Activity for WEE1 Inhibitor, APR-1051, Including Second Partial Response in Ongoing ACESOT-1051 Trial
Finviz2026-02-18 13:06:39
Humacyte Announces Presentation of Symvess Long-Term Safety and Efficacy Results at VESS Meeting
Finviz2026-02-18 13:06:41
Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need
Finviz2026-02-18 13:18:37
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
Finviz2026-02-18 13:33:36
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
Finviz2026-02-18 13:48:54
Kodiak AI Appoints Chet Gryczan to Lead Its Defense Vertical
Finviz2026-02-18 14:03:34
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
Finviz2026-02-18 14:09:35
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
Finviz2026-02-18 14:30:10
Barrett Business Services (BBSI) Earnings Expected to Grow: Should You Buy?
Finviz2026-02-18 16:04:06
NBIS: A Vertically Integrated AI Infrastructure Powerhouse
Finviz2026-02-18 16:33:05
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Finviz2026-02-18 16:42:43
From Property Management to Performance Management: AppFolio Report Shows AI Leaders Pulling Ahead
Finviz2026-02-18 17:03:46
McDonald’s introduces high-protein menu items aimed at GLP-1 users for trial
101 finance2026-02-18 20:33:14
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-18 21:09:41
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-02-18 21:09:42
XOMA Royalty to Present at Investor Conferences in March
Finviz2026-02-18 21:33:41
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Finviz2026-02-18 12:03:22
Upwork Announces $300 Million Share Repurchase Program
Finviz2026-02-18 12:03:22
Amazon Abandons Blue Jay Warehouse Robot In Less Than Six Months, Pivots To New Technologies: Report
Finviz2026-02-18 12:21:40
SailPoint Announces Date of Fiscal Fourth Quarter and Full Year 2026 Earnings Conference Call
Finviz2026-02-18 13:03:47
Aprea Therapeutics Announces Additional Positive Clinical Activity for WEE1 Inhibitor, APR-1051, Including Second Partial Response in Ongoing ACESOT-1051 Trial
Finviz2026-02-18 13:06:39
Humacyte Announces Presentation of Symvess Long-Term Safety and Efficacy Results at VESS Meeting
Finviz2026-02-18 13:06:41
Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need
Finviz2026-02-18 13:18:37
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
Finviz2026-02-18 13:33:36
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
Finviz2026-02-18 13:48:54
Kodiak AI Appoints Chet Gryczan to Lead Its Defense Vertical
Finviz2026-02-18 14:03:34
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
Finviz2026-02-18 14:09:35
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
Finviz2026-02-18 14:30:10
Barrett Business Services (BBSI) Earnings Expected to Grow: Should You Buy?
Finviz2026-02-18 16:04:06
NBIS: A Vertically Integrated AI Infrastructure Powerhouse
Finviz2026-02-18 16:33:05
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Finviz2026-02-18 16:42:43
From Property Management to Performance Management: AppFolio Report Shows AI Leaders Pulling Ahead
Finviz2026-02-18 17:03:46
McDonald’s introduces high-protein menu items aimed at GLP-1 users for trial
101 finance2026-02-18 20:33:14
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-18 21:09:41
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-02-18 21:09:42
XOMA Royalty to Present at Investor Conferences in March
Finviz2026-02-18 21:33:41
TSE:5621 stock price change
On the last trading day, TSE:5621 stock closed at 1654.00 JPY, with a price change of -4.89% for the day.
Trade stock futuresTSE:5621 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more